Clinical Trial Update: Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is investigating Triamcinolone Acetonide as an adjunct to verteporfin photodynamic therapy for age-related macular degeneration…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Canadian Retinal Trials Group | Conditions: Age-Related Macular Degeneration | Phase 2, Phase 3 | Status: UNKNOWN